Two different compounds (pictured above) were generated using zinc (left) and manganese (right). Whilst these two compounds ‘look’ very similar the zinc compound demonstrated excellent anti-cancer activity and selectivity towards a range of cancers in the laboratory whereas the manganese compound was comparatively much more toxic, meaning there was more anti-cancer activity at a lower concentration, with similar selectivity compared to current drugs tested.
A team of scientists at the University of Huddersfield has discovered chemical systems that self-assemble into molecular capsules which are highly toxic towards human cancer cells of a range of different tumour types, and which have demonstrated unprecedented cancer selectivity in the laboratory that, in some cases, are many thousands of times more toxic to the cancer cells compared to healthy, normal cells
ONE of the most challenging aspects of cancer treatment is the huge variety of different tumours that can occur with each one potentially requiring a different solution because unfortunately, one drug does NOT fit all. In addition, another major issue of many current drugs is their poor selectivity towards cancers resulting in problems such as normal tissue toxicity, severe side effects and the development of drug resistance.
Now, a team of scientists at the University of Huddersfield is researching how to combat these challenges by using “self-assembled” drugs and although the research is in its very early stages, they’ve already had a breakthrough.
The science behind self-assembly
Self-assembly is the ability to instruct chemical systems with specific information so in the correct environment they will spontaneously generate biologically active compounds. Using this process many different compounds can be rapidly and easily formed with each different self-assembled drug having different chemotherapy properties.
“In the future, it may be possible to target many cancers through this approach with the correct drug ‘self-assembled’ in such a manner to be selective for a specific cancer.”
Professor Craig Rice
In an article published by the journal Nature Communications, the University’s Professor Roger Phillips, Dr Simon Allison and Professor Craig Rice demonstrate chemical systems that self-assemble into molecular capsules which are highly toxic towards human cancer cells of a range of different tumour types.
More importantly, they show unprecedented cancer selectivity in the laboratory that, in some cases, are many thousands of times more toxic to the cancer cells compared to healthy, normal cells.
Cancer therapy without severe side-effects
Eventually, if similar results are obtained in more complex testing systems including in patients, and once considered safe after careful testing, it could offer the possibility of being able to treat cancers without the severe side effects commonly associated with chemotherapy drugs.
“Anti-cancer drug discovery and development can be enormously time consuming and expensive with a particular drug only being effective against a relatively small number of cancers with specific shared properties,” explained Professor Rice who heads the University’s Department of Chemical Sciences and is also the Director of the Structural, Molecular and Dynamic Modelling Centre within the School of Applied Sciences.
“In the future, it may be possible to target many cancers through this approach with the correct drug ‘self-assembled’ in such a manner to be selective for a specific cancer,” said Professor Rice.
Targeting hard-to-treat cancers
The research could also pave the way in targeting hard-to-treat cancers for which commonly used chemotherapy drugs have little or no effect.
The published studies show the new potential drug can be assembled with either zinc, copper, or manganese, with the three metal ions imparting significantly different chemotherapeutic properties via different mechanisms dependent upon which metal ion is used.
“It is this which allows the generation of different chemical systems each of which may have specificity for different cancers,” he said.
Original Article: Cancer therapy breakthrough in vitro using self-assembled drugs
More from: University of Huddersfield
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Self-assembled drugs
- Columbia University has a doxxing problem
I literally did not leave my apartment the days my friends told me about it,” a computer science undergraduate, whose name was listed on the truck, told me outside the Columbia encampment on Tuesday ...
- Scientists learn from caterpillars how to create self-assembling capsules for drug delivery
Self-assembling molecules that spontaneously organize themselves to form complex structures are common in nature. For example, the tough outer layer of insects, called the cuticle, is rich in proteins ...
- Lessons in Democracy From F.C. Porto
A powerful president and a popular rival highlight an election that has already featured fights, arrests and accusations of intimidation.
- Whatever happened to Biden’s public option?
The president and his congressional allies were vocal proponents of a government-run alternative to commercial insurance back in 2020. But the health-care industry has kept the idea bottled up.
- Learning from caterpillars to create self-assembling capsules for drug delivery
The researchers are applying for a patent for their innovation, based on their study findings that were reported in Nature Nanotechnology ("Self-assembly of peptide nanocapsules by a solvent ...
Go deeper with Google Headlines on:
Self-assembled drugs
[google_news title=”” keyword=”self-assembled drugs” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Cancer therapy without severe side-effects
- Side effects of immunotherapy for cancer treatment
Trenton Stewart of Davenport is charged with forging checks stolen during break-in. Moline City Council endorsed the $6.8 million redevelopment proposal to convert the old JCPenny building to ...
- Side effects of 'magic mushrooms' similar to regular antidepressants
People in a new study who took psilocybin often experienced headache, nausea, anxiety, dizziness and elevated blood pressure -- side effects similar to those seen with regular antidepressants.
- ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has approved ANKTIVA (N-803, or nogapendekin alfa inbakicept-pmln) plus ...
- Scientists making progress in less toxic cancer treatment called immunotherapy
Scientists are making progress in using less toxic immunotherapy instead of traditional chemotherapy to fight cancer.
- What Is Pancreatic Cancer?
Pancreatic cancer develops when abnormal cells in the pancreas grow uncontrollably, causing symptoms like fatigue, jaundice, and urinary changes.
Go deeper with Google Headlines on:
Cancer therapy without severe side-effects
[google_news title=”” keyword=”Cancer therapy without severe side-effects” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]